Skip to main content
. Author manuscript; available in PMC: 2012 Sep 10.
Published in final edited form as: AIDS. 2011 Sep 10;25(14):1753–1760. doi: 10.1097/QAD.0b013e3283463eec

Figure Three.

Figure Three

Distribution of Total Financial Costs in Successive 6-Month Periods, from Start of HIV Treatment Scale-Up in Each Site through 2006–07δ.

* Other Investments include construction/renovation, equipment and training.

$ Other Recurrent Costs include non-ARV medications, laboratory supplies, other supplies, building rental, travel expenses, utilities and contracted services.

δ Figure excludes Botswana sites.